Reading Between the Lines on Research – Part Two

I promised you an explanation of RCTs – here goes (brace yourself).  You are a big pharmaceutical company and you want to know if your (very expensive) drug works.  You get yourself a number of people who are happy to go on a drug trial.  Many people with a disease, such as cancer, willingly take…

Continue Reading →